Abbott Laboratories vs. UnitedHealth: Does Health Innovation or Health Insurance Make for a Better Stock to Buy?The Motley Fool · 1 hr ago
The Dividend Aristocrats Ranked By Quality Scores (October 2026)Seeking Alpha · 1 day ago
Abbott presents new ESMO data showing 30-percent absolute improvement in sensitivity with the whole-genome sequencing Oncodetect® test in colorectal cancerPRNewsWire · 1 day ago
Abbott Laboratories $ABT Shares Sold by Axxcess Wealth Management LLCDefense World · 1 day ago
Abbott's Q3 Earnings Call Focuses on Nutrition Spin-Off and OutlookZacks Investment Research · 2 days ago
Cologuard Is Working—So Why Isn't Abbott Stock?MarketBeat · 2 days agoAbbott Laboratories, along with its affiliated entities, is a global healthcare enterprise dedicated to the research, development, manufacturing, and worldwide distribution of a diverse portfolio of health solutions. The company operates through four primary divisions: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. In the Established Pharmaceutical Products segment, Abbott provides generic medications designed to treat a wide array of conditions, including pancreatic exocrine insufficiency, irritable bowel syndrome or biliary spasm, intrahepatic cholestasis or depressive symptoms, gynecological disorders, hormone replacement therapy, dyslipidemia, hypertension, hypothyroidism, Ménière's disease and vestibular vertigo, pain, fever, inflammation, and migraine.
| Date | Est. | Actual | |
|---|---|---|---|
| Oct 21, 2026 | $1.42 | $1.42 | Beat |
| Jul 16, 2026 | $1.28 | $1.31 | Beat |
| Apr 16, 2026 | $1.14 | $1.15 | Beat |
| Jan 22, 2026 | $1.50 | $1.50 | Beat |
| Oct 15, 2025 | $1.30 | $1.30 | Beat |
| Jul 17, 2025 | $1.26 | $1.26 | Beat |